A community-based group randomized trial to increase aspirin use for primary prevention of cardiovascular disease: Study protocol and baseline results for the “Ask About Aspirin” initiative-Reference-Cited by-同舟云学术

A community-based group randomized trial to increase aspirin use for primary prevention of cardiovascular disease: Study protocol and baseline results for the “Ask About Aspirin” initiative

Published:2021-06 Issue: Volume:22 Page:100772
ISSN:2451-8654
Container-title:Contemporary Clinical Trials Communications
language:en
Short-container-title:Contemporary Clinical Trials Communications

Author:

Duval Sue^ORCID,Van't Hof Jeremy R.,Oldenburg Niki C.^ORCID,Eder Milton^ORCID,Finnegan John R.,Luepker Russell V.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference42 articles.

1. Heart disease and stroke statistics—2020 update: a report from the American Heart Association;Virani;Circulation,2020

2. The “Million Hearts” initiative--preventing heart attacks and strokes;Frieden;N. Engl. J. Med.,2011

3. Aspirin for the prevention of cardiovascular disease : U. S. Preventive Services Task Force recommendation statement;Ann. Intern. Med.,2009

4. Population trends in aspirin use for cardiovascular disease prevention 1980-2009: the Minnesota Heart Survey;Luepker;J. Am. Heart Assoc.,2015

5. Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry;Hira;J. Am. Coll. Cardiol.,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regular aspirin use among a sample of American Indians/Alaskan Natives in the Upper Midwest region of the United States;Preventive Medicine Reports;2024-01

2. Association of a Community Population and Clinic Education Intervention Program With Guideline-Based Aspirin Use for Primary Prevention of Cardiovascular Disease;JAMA Network Open;2022-05-10